TAKE NSE filing

Take Solutions Appoints New Director, Auditors, and Plans Registered Office Shift

The RealCase readMedium impact Neutral

Take Solutions appointed Mr. Vilas Munis as Additional Director and regularized Mr. Parmeshvar Dhangare's appointment. The company will shift its registered office from Tamil Nadu to Maharashtra and regularized new auditors. An EOGM is scheduled for March 7, 2026, for shareholder approval. The Board will also review a promoter reclassification request.

Why it matters

The appointment of new directors, regularization of auditors, and especially the proposed shift of the registered office are material corporate actions that could have administrative and operational implications for the company. The review of a promoter reclassification request also adds to the potential impact.

The market read

The announcement details several board-level decisions including director appointments, auditor regularization, and a proposed shift in the registered office. While these are significant corporate actions, they do not immediately indicate a positive or negative financial impact.

Take Solutions Limited announced the outcome of its Board Meeting held on February 11, 2026. The Board approved the appointment of Mr. Vilas Munis as an Additional Non-Executive Non-Independent Director. Additionally, the appointment of Mr. Parmeshvar Dhangare as a Non-Executive Non-Independent Director was regularized, subject to member approval.

The company also regularized the appointment of M/s. Venkat and Rangaa LLP as Statutory Auditors to fill a casual vacancy caused by the resignation of M/s. Sundar Srini & Sridhar. A significant decision was the approval to shift the registered office from Tamil Nadu to Maharashtra, which requires shareholder and Regional Director approval.

An Extra Ordinary General Meeting (EOGM) has been scheduled for March 7, 2026, to obtain member approval for these changes. Remote e-voting will commence on March 4, 2026, and conclude on March 6, 2026, with a cut-off date of February 28, 2026, for eligibility. M/s. Hemang Satra & Associates has been appointed as the Scrutinizer.

The Board also reviewed the progress of its AI-driven Diagnostic & Preventive Health Care Platform development. Furthermore, the Board noted a request from Mr. Srinivasan H R for reclassification from 'Promoter' to 'Public' category, which will be examined in detail at the next Board Meeting scheduled for February 14, 2026. The Board meeting commenced at 5:30 PM and concluded at 6:30 PM.

Filing to action

What to do with a filing like this

Take Solutions Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Take Solutions Limited. Read the original for the full detail.

View original filing